Trial of Panitumumab/Cisplatin/Fluorouracil With XRT in Esophageal Cancer

This study has been terminated.
(slow accrual)
Sponsor:
Collaborator:
Amgen
Information provided by (Responsible Party):
University of Wisconsin, Madison
ClinicalTrials.gov Identifier:
NCT01128387
First received: May 17, 2010
Last updated: January 14, 2015
Last verified: January 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: December 2015
  Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)